Giza Venture Capital

Total investments

131

Average round size

10M

Portfolio companies

80

Rounds per year

4.23

Lead investments

26

Follow on index

0.39

Exits

49

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
InternetSoftwareAnalyticsInformation TechnologyMobileHealth CareSaaSEnterprise SoftwareMedical DeviceMedical

Summary

Giza Venture Capital appeared to be the VC, which was created in 1992. The venture was found in Asia in Israel. The main department of described VC is located in the Tel Aviv.

This organization was formed by Zeev Holtzman, Zvi Schechter. We also calculated 4 valuable employees in our database.

The real fund results show that this VC is 3 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2013. This Giza Venture Capital works on 6 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in 2-6 deals per year. The important activity for fund was in 2007. Despite it in 2019 the fund had an activity. The typical startup value when the investment from Giza Venture Capital is 100-500 millions dollars.

The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Medical Device, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight WalkMe, Mitralign, Mintigo.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Giza Venture Capital, startups are often financed by Pitango Venture Capital, Oxford Bioscience Partners, Benchmark. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures, Genesis Partners, Benchmark. In the next rounds fund is usually obtained by Oxford Bioscience Partners, Benchmark, Bessemer Venture Partners.

Show more

Investments analytics

Analytics

Total investments
131
Lead investments
26
Exits
49
Rounds per year
4.23
Follow on index
0.39
Investments by industry
  • Software (27)
  • Information Technology (26)
  • Health Care (25)
  • Analytics (22)
  • Mobile (21)
  • Show 110 more
Investments by region
  • United States (62)
  • Israel (57)
  • Germany (1)
  • China (4)
  • Taiwan (3)
  • Show 3 more
Peak activity year
2006
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
19
Avg. valuation at time of investment
65M
Group Appearance index
0.81
Avg. company exit year
8
Avg. multiplicator
2.51
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Logz.io 17 Feb 2015 Analytics, Artificial Intelligence, SaaS, Enterprise Software, Big Data Seed 1M United States, Massachusetts, Boston
luzverde 01 Jan 2022 Retail, Retail Technology, Consumer, Local Business Seed 500K Ecuador, Pichincha, Ecuador
Soluto 03 Nov 2009 Cloud Computing, iOS, Mobile Devices Early Stage Venture 6M Tel Aviv District, Tel Aviv-Yafo, Israel

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.